Results 141 to 150 of about 1,098,931 (194)

Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clock. [PDF]

Blood Adv
Minotti G.
europepmc   +1 more source

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study. [PDF]

Am J Hematol
Ghosh N, Eyre TA, Brown JR, Lamanna N, Manzoor BS, Coombs CC, Tuncer HH, Ujjani C, Leslie LA, Roeker LE, Davids MS, Rhodes JM, Skarbnik AP, Sinai W, Fleury I, Hill BT, Martinez-Calle N, Barr PM, Jawaid D, Emechebe N, Pearson L, Lansigan F, Choi Y, Jensen CE, Fakhri B, Stephens DM, Marx SE, Schuster SJ, Coyle M, Pivneva I, Watson T, Guerin A, Shadman M.   +32 more
europepmc   +1 more source

Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors. [PDF]

World J Gastroenterol
Liu WN, Dai MS, Lin F, Lin GM.
europepmc   +1 more source

Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk. [PDF]

Case Rep Hematol
Erblich T, Manisty C, Gribben J.
europepmc   +1 more source

Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Ke L, Li S, Huang D, Wang Y.
europepmc   +1 more source

Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched Analysis. [PDF]

Open Forum Infect Dis
Agudelo Higuita NI, Chastain DB, Scott B, Sahra S, Vargas Barahona L, Henao Cordero J, Lee ALH, Tuells J, Henao-Martínez AF.   +8 more
europepmc   +1 more source

Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis. [PDF]

Ann Hematol
Yin S, Zheng X, Zhang W, Zhao H, Zhang R, Li W, Chen F.   +6 more
europepmc   +1 more source